The European OTC drugs market is anticipated to grow at a CAGR of 5.9% during the forecast period (2019-2025). The market growth is attributed to the increasing trend of self-medication in the region coupled with the increasing requirement for reducing healthcare costs. Major economies covered in the study of the European OTC drugs industry report covers the analysis of the UK, Germany, Italy, Spain, France, and the Rest of Europe. Among these, Germany is estimated to contribute a significant share in the market.

A full report of European OTC Drugs Market is available at: https://www.omrglobal.com/industry-reports/european-over-the-counter-otc-drugs-market

Germany is home to Europe’s largest while the fourth-largest pharmaceuticals markets of the globe. With the presence of highly attractive R&D locations, the country ranks first and second in terms of clinical trials in Europe and the globe respectively. In Germany, the increasing aging population coupled with the growing awareness regarding health and fitness continues to drive sales in the consumer healthcare sector. The OTC drugs market in Germany is estimated to grow significantly owing to innovation and new product launches by some of the pharmaceuticals giants such as AstraZeneca Plc, Bayer AG, Novartis, International AG, and others.

To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/european-over-the-counter-otc-drugs-market

For instance, in July 2020, Novartis announced a new initiative to help patients in low-income and lower-middle-income countries access affordable medicines to treat the major symptoms of COVID-19. The Novartis COVID-19 portfolio includes 15 generic and OTC medicines from its Sandoz division for gastrointestinal illness, acute respiratory symptoms, pneumonia as well as septic shock.

Market Coverage

• Market numbers available for – 2018-2025
• Base year- 2018
• Forecast period- 2019-2025
• Segment Covered-
o By Product Type
o By Distribution Channel
Countries Covered-
o UK
o Germany
o Italy
o Spain
o France
o Rest of Europe
• Competitive Landscape- AstraZeneca Plc, Bayer AG, Novartis International AG, Sanofi SA, Perrigo Co. Plc., and Others

Key Questions Addressed by the Report

• What is the current market size and growth rate in the forecast period?
• Which segment dominates the market in the base year?
• Which segment will project the fastest growth in the market?
• Impact on market growth due to the COVID-19 pandemic?
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/european-over-the-counter-otc-drugs-market

European OTC Drugs Market Report Segment

By Product Type

• Analgesics & Pain Relievers
• Cough, Cold & Flu Products
• Vitamins & Mineral Supplements
• Ophthalmic Products
• Others

By Distribution Channel

• Retail & Supermarket
• Online Platform

Company Profiles

• AstraZeneca PLC
• Bayer AG
• Boehringer Ingelheim International GmbH
• GlaxoSmithKline Plc
• Johnson & Johnson Services Inc.
• Merck KGaA
• Novartis international AG
• Perrigo Co. plc
• Reckitt Benckiser Group plc
• Sanofi SA

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit https://www.omrglobal.com


Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404